Mckesson (MCK) Land & Improvements (2025 - 2026)
Mckesson (MCK) posted quarterly Land & Improvements of $102.0 million for Q1 2026, down 1.92% year-over-year from $104.0 million in Q1 2025, and down 1.92% quarter-over-quarter from $104.0 million in Q1 2025.
Mckesson (MCK) Land & Improvements (2025 - 2026) Analysis & Trends
Mckesson (MCK) has reported Land & Improvements for 2 consecutive years, with $102.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Land & Improvements fell 1.92% year-over-year to $102.0 million; the TTM figure through Mar 2026 stood at $102.0 million (down 1.92% YoY), while the FY2026 annual figure was $102.0 million, down 1.92% from the prior year.
- Land & Improvements eased to $102.0 million in Q1 2026 per MCK's latest filing, from $104.0 million in the prior quarter.
- Across five years, Land & Improvements topped out at $104.0 million in Q1 2025 and bottomed at $102.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | - |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | - |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | - |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | - |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | - |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | - |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | - |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | 3.66 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.00 Mn |
| Mar 31, 2025 | 104.00 Mn |